Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients

Background: Bladder cancer is one of the most common malignancies. So far, no effective biomarker for bladder cancer prognosis has been identified. Aberrant DNA methylation is frequently observed in the bladder cancer and holds considerable promise as a biomarker for predicting the overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Huamei, Kan, Lijuan, Ou, Tong, Chen, Dayang, Dou, Xiaowen, Wu, Wei, Ji, Xiang, Wang, Mengmeng, Zong, Zengyan, Mo, Hongmei, Zhang, Xiuming, Xiong, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286875/
https://www.ncbi.nlm.nih.gov/pubmed/32441304
http://dx.doi.org/10.1042/BSR20194432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286875/
https://www.ncbi.nlm.nih.gov/pubmed/32441304
http://dx.doi.org/10.1042/BSR20194432

Ejemplares similares